Troy Edward Wilson - 26 Jan 2022 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Role
President and CEO, Director
Signature
Teresa Bair, Attorney-in-fact for Troy E. Wilson
Issuer symbol
KURA
Transactions as of
26 Jan 2022
Net transactions value
$0
Form type
4
Filing time
28 Jan 2022, 15:08:04 UTC
Previous filing
16 Jun 2021
Next filing
16 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KURA Option to purchase common stock Award $0 +495,000 $0.000000 495,000 26 Jan 2022 Common Stock 495,000 $14.15 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests in 48 equal monthly installments commencing on the grant date.